0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
In Vitro Colorectal Cancer Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: October 2024
|
Report Code: QYRE-Auto-25W8336
Home | Market Reports | Health| Medical Facilities & Services| Medical Procedures
Global In Vitro Colorectal Cancer Testing Market Insights Forecast to 2028
BUY CHAPTERS

In Vitro Colorectal Cancer Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-25W8336
Report
October 2024
Pages:90
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

In Vitro Colorectal Cancer Testing - Market Size

The global market for In Vitro Colorectal Cancer Testing was estimated to be worth US$ 851.2 million in 2023 and is forecast to a readjusted size of US$ 1062.4 million by 2030 with a CAGR of 3.3% during the forecast period 2024-2030

In Vitro Colorectal Cancer Testing - Market

In Vitro Colorectal Cancer Testing - Market

Screening for colorectal cancer allows for the early detection of cancer when it is highly curable, as well as the detection of growths (polyps) that might eventually become cancer.
North American market for In Vitro Colorectal Cancer Testing was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for In Vitro Colorectal Cancer Testing was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for In Vitro Colorectal Cancer Testing was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of In Vitro Colorectal Cancer Testing include Abbott Laboratories, BioTime, Danaher Corporation, Epigenomics AG, Exact Sciences Corporation, LifeLabs Medical Laboratory Services, Novigenix SA, Quest Diagnostics and Sysmex Corporation, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for In Vitro Colorectal Cancer Testing, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of In Vitro Colorectal Cancer Testing by region & country, by Type, and by Application.
The In Vitro Colorectal Cancer Testing market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In Vitro Colorectal Cancer Testing.
Market Segmentation

Scope of In Vitro Colorectal Cancer Testing - Market Report

Report Metric Details
Report Name In Vitro Colorectal Cancer Testing - Market
Forecasted market size in 2030 US$ 1062.4 million
CAGR 3.3%
Forecasted years 2024 - 2030
Segment by Type:
  • Fecal Occult Blood Tests
  • Stool Biomarkers Tests
  • Blood Biomarker Tests
Segment by Application
  • Ambulatory Surgical Centers
  • Hospitals
  • Physical Examination Center
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Abbott Laboratories, BioTime, Danaher Corporation, Epigenomics AG, Exact Sciences Corporation, LifeLabs Medical Laboratory Services, Novigenix SA, Quest Diagnostics, Sysmex Corporation
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of In Vitro Colorectal Cancer Testing manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of In Vitro Colorectal Cancer Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of In Vitro Colorectal Cancer Testing in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the In Vitro Colorectal Cancer Testing - Market size in 2030?

Ans: The In Vitro Colorectal Cancer Testing - Market size in 2030 will be US$ 1062.4 million.

Who are the main players in the In Vitro Colorectal Cancer Testing - Market report?

Ans: The main players in the In Vitro Colorectal Cancer Testing - Market are Abbott Laboratories, BioTime, Danaher Corporation, Epigenomics AG, Exact Sciences Corporation, LifeLabs Medical Laboratory Services, Novigenix SA, Quest Diagnostics, Sysmex Corporation

What are the Application segmentation covered in the In Vitro Colorectal Cancer Testing - Market report?

Ans: The Applications covered in the In Vitro Colorectal Cancer Testing - Market report are Ambulatory Surgical Centers, Hospitals, Physical Examination Center

What are the Type segmentation covered in the In Vitro Colorectal Cancer Testing - Market report?

Ans: The Types covered in the In Vitro Colorectal Cancer Testing - Market report are Fecal Occult Blood Tests, Stool Biomarkers Tests, Blood Biomarker Tests

1 Market Overview
1.1 In Vitro Colorectal Cancer Testing Product Introduction
1.2 Global In Vitro Colorectal Cancer Testing Market Size Forecast
1.3 In Vitro Colorectal Cancer Testing Market Trends & Drivers
1.3.1 In Vitro Colorectal Cancer Testing Industry Trends
1.3.2 In Vitro Colorectal Cancer Testing Market Drivers & Opportunity
1.3.3 In Vitro Colorectal Cancer Testing Market Challenges
1.3.4 In Vitro Colorectal Cancer Testing Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global In Vitro Colorectal Cancer Testing Players Revenue Ranking (2023)
2.2 Global In Vitro Colorectal Cancer Testing Revenue by Company (2019-2024)
2.3 Key Companies In Vitro Colorectal Cancer Testing Manufacturing Base Distribution and Headquarters
2.4 Key Companies In Vitro Colorectal Cancer Testing Product Offered
2.5 Key Companies Time to Begin Mass Production of In Vitro Colorectal Cancer Testing
2.6 In Vitro Colorectal Cancer Testing Market Competitive Analysis
2.6.1 In Vitro Colorectal Cancer Testing Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by In Vitro Colorectal Cancer Testing Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In Vitro Colorectal Cancer Testing as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Fecal Occult Blood Tests
3.1.2 Stool Biomarkers Tests
3.1.3 Blood Biomarker Tests
3.2 Global In Vitro Colorectal Cancer Testing Sales Value by Type
3.2.1 Global In Vitro Colorectal Cancer Testing Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global In Vitro Colorectal Cancer Testing Sales Value, by Type (2019-2030)
3.2.3 Global In Vitro Colorectal Cancer Testing Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Ambulatory Surgical Centers
4.1.2 Hospitals
4.1.3 Physical Examination Center
4.2 Global In Vitro Colorectal Cancer Testing Sales Value by Application
4.2.1 Global In Vitro Colorectal Cancer Testing Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global In Vitro Colorectal Cancer Testing Sales Value, by Application (2019-2030)
4.2.3 Global In Vitro Colorectal Cancer Testing Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global In Vitro Colorectal Cancer Testing Sales Value by Region
5.1.1 Global In Vitro Colorectal Cancer Testing Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global In Vitro Colorectal Cancer Testing Sales Value by Region (2019-2024)
5.1.3 Global In Vitro Colorectal Cancer Testing Sales Value by Region (2025-2030)
5.1.4 Global In Vitro Colorectal Cancer Testing Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America In Vitro Colorectal Cancer Testing Sales Value, 2019-2030
5.2.2 North America In Vitro Colorectal Cancer Testing Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe In Vitro Colorectal Cancer Testing Sales Value, 2019-2030
5.3.2 Europe In Vitro Colorectal Cancer Testing Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific In Vitro Colorectal Cancer Testing Sales Value, 2019-2030
5.4.2 Asia Pacific In Vitro Colorectal Cancer Testing Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America In Vitro Colorectal Cancer Testing Sales Value, 2019-2030
5.5.2 South America In Vitro Colorectal Cancer Testing Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa In Vitro Colorectal Cancer Testing Sales Value, 2019-2030
5.6.2 Middle East & Africa In Vitro Colorectal Cancer Testing Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions In Vitro Colorectal Cancer Testing Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions In Vitro Colorectal Cancer Testing Sales Value
6.3 United States
6.3.1 United States In Vitro Colorectal Cancer Testing Sales Value, 2019-2030
6.3.2 United States In Vitro Colorectal Cancer Testing Sales Value by Type (%), 2023 VS 2030
6.3.3 United States In Vitro Colorectal Cancer Testing Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe In Vitro Colorectal Cancer Testing Sales Value, 2019-2030
6.4.2 Europe In Vitro Colorectal Cancer Testing Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe In Vitro Colorectal Cancer Testing Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China In Vitro Colorectal Cancer Testing Sales Value, 2019-2030
6.5.2 China In Vitro Colorectal Cancer Testing Sales Value by Type (%), 2023 VS 2030
6.5.3 China In Vitro Colorectal Cancer Testing Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan In Vitro Colorectal Cancer Testing Sales Value, 2019-2030
6.6.2 Japan In Vitro Colorectal Cancer Testing Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan In Vitro Colorectal Cancer Testing Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea In Vitro Colorectal Cancer Testing Sales Value, 2019-2030
6.7.2 South Korea In Vitro Colorectal Cancer Testing Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea In Vitro Colorectal Cancer Testing Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia In Vitro Colorectal Cancer Testing Sales Value, 2019-2030
6.8.2 Southeast Asia In Vitro Colorectal Cancer Testing Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia In Vitro Colorectal Cancer Testing Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India In Vitro Colorectal Cancer Testing Sales Value, 2019-2030
6.9.2 India In Vitro Colorectal Cancer Testing Sales Value by Type (%), 2023 VS 2030
6.9.3 India In Vitro Colorectal Cancer Testing Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Profile
7.1.2 Abbott Laboratories Main Business
7.1.3 Abbott Laboratories In Vitro Colorectal Cancer Testing Products, Services and Solutions
7.1.4 Abbott Laboratories In Vitro Colorectal Cancer Testing Revenue (US$ Million) & (2019-2024)
7.1.5 Abbott Laboratories Recent Developments
7.2 BioTime
7.2.1 BioTime Profile
7.2.2 BioTime Main Business
7.2.3 BioTime In Vitro Colorectal Cancer Testing Products, Services and Solutions
7.2.4 BioTime In Vitro Colorectal Cancer Testing Revenue (US$ Million) & (2019-2024)
7.2.5 BioTime Recent Developments
7.3 Danaher Corporation
7.3.1 Danaher Corporation Profile
7.3.2 Danaher Corporation Main Business
7.3.3 Danaher Corporation In Vitro Colorectal Cancer Testing Products, Services and Solutions
7.3.4 Danaher Corporation In Vitro Colorectal Cancer Testing Revenue (US$ Million) & (2019-2024)
7.3.5 Epigenomics AG Recent Developments
7.4 Epigenomics AG
7.4.1 Epigenomics AG Profile
7.4.2 Epigenomics AG Main Business
7.4.3 Epigenomics AG In Vitro Colorectal Cancer Testing Products, Services and Solutions
7.4.4 Epigenomics AG In Vitro Colorectal Cancer Testing Revenue (US$ Million) & (2019-2024)
7.4.5 Epigenomics AG Recent Developments
7.5 Exact Sciences Corporation
7.5.1 Exact Sciences Corporation Profile
7.5.2 Exact Sciences Corporation Main Business
7.5.3 Exact Sciences Corporation In Vitro Colorectal Cancer Testing Products, Services and Solutions
7.5.4 Exact Sciences Corporation In Vitro Colorectal Cancer Testing Revenue (US$ Million) & (2019-2024)
7.5.5 Exact Sciences Corporation Recent Developments
7.6 LifeLabs Medical Laboratory Services
7.6.1 LifeLabs Medical Laboratory Services Profile
7.6.2 LifeLabs Medical Laboratory Services Main Business
7.6.3 LifeLabs Medical Laboratory Services In Vitro Colorectal Cancer Testing Products, Services and Solutions
7.6.4 LifeLabs Medical Laboratory Services In Vitro Colorectal Cancer Testing Revenue (US$ Million) & (2019-2024)
7.6.5 LifeLabs Medical Laboratory Services Recent Developments
7.7 Novigenix SA
7.7.1 Novigenix SA Profile
7.7.2 Novigenix SA Main Business
7.7.3 Novigenix SA In Vitro Colorectal Cancer Testing Products, Services and Solutions
7.7.4 Novigenix SA In Vitro Colorectal Cancer Testing Revenue (US$ Million) & (2019-2024)
7.7.5 Novigenix SA Recent Developments
7.8 Quest Diagnostics
7.8.1 Quest Diagnostics Profile
7.8.2 Quest Diagnostics Main Business
7.8.3 Quest Diagnostics In Vitro Colorectal Cancer Testing Products, Services and Solutions
7.8.4 Quest Diagnostics In Vitro Colorectal Cancer Testing Revenue (US$ Million) & (2019-2024)
7.8.5 Quest Diagnostics Recent Developments
7.9 Sysmex Corporation
7.9.1 Sysmex Corporation Profile
7.9.2 Sysmex Corporation Main Business
7.9.3 Sysmex Corporation In Vitro Colorectal Cancer Testing Products, Services and Solutions
7.9.4 Sysmex Corporation In Vitro Colorectal Cancer Testing Revenue (US$ Million) & (2019-2024)
7.9.5 Sysmex Corporation Recent Developments
8 Industry Chain Analysis
8.1 In Vitro Colorectal Cancer Testing Industrial Chain
8.2 In Vitro Colorectal Cancer Testing Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 In Vitro Colorectal Cancer Testing Sales Model
8.5.2 Sales Channel
8.5.3 In Vitro Colorectal Cancer Testing Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. In Vitro Colorectal Cancer Testing Market Trends
    Table 2. In Vitro Colorectal Cancer Testing Market Drivers & Opportunity
    Table 3. In Vitro Colorectal Cancer Testing Market Challenges
    Table 4. In Vitro Colorectal Cancer Testing Market Restraints
    Table 5. Global In Vitro Colorectal Cancer Testing Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global In Vitro Colorectal Cancer Testing Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies In Vitro Colorectal Cancer Testing Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies In Vitro Colorectal Cancer Testing Product Type
    Table 9. Key Companies Time to Begin Mass Production of In Vitro Colorectal Cancer Testing
    Table 10. Global In Vitro Colorectal Cancer Testing Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In Vitro Colorectal Cancer Testing as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global In Vitro Colorectal Cancer Testing Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global In Vitro Colorectal Cancer Testing Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global In Vitro Colorectal Cancer Testing Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global In Vitro Colorectal Cancer Testing Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global In Vitro Colorectal Cancer Testing Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global In Vitro Colorectal Cancer Testing Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global In Vitro Colorectal Cancer Testing Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global In Vitro Colorectal Cancer Testing Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global In Vitro Colorectal Cancer Testing Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global In Vitro Colorectal Cancer Testing Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global In Vitro Colorectal Cancer Testing Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global In Vitro Colorectal Cancer Testing Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global In Vitro Colorectal Cancer Testing Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global In Vitro Colorectal Cancer Testing Sales Value by Region (2019-2024) & (%)
    Table 27. Global In Vitro Colorectal Cancer Testing Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions In Vitro Colorectal Cancer Testing Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions In Vitro Colorectal Cancer Testing Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions In Vitro Colorectal Cancer Testing Sales Value, (2025-2030) & (US$ Million)
    Table 31. Abbott Laboratories Basic Information List
    Table 32. Abbott Laboratories Description and Business Overview
    Table 33. Abbott Laboratories In Vitro Colorectal Cancer Testing Products, Services and Solutions
    Table 34. Revenue (US$ Million) in In Vitro Colorectal Cancer Testing Business of Abbott Laboratories (2019-2024)
    Table 35. Abbott Laboratories Recent Developments
    Table 36. BioTime Basic Information List
    Table 37. BioTime Description and Business Overview
    Table 38. BioTime In Vitro Colorectal Cancer Testing Products, Services and Solutions
    Table 39. Revenue (US$ Million) in In Vitro Colorectal Cancer Testing Business of BioTime (2019-2024)
    Table 40. BioTime Recent Developments
    Table 41. Danaher Corporation Basic Information List
    Table 42. Danaher Corporation Description and Business Overview
    Table 43. Danaher Corporation In Vitro Colorectal Cancer Testing Products, Services and Solutions
    Table 44. Revenue (US$ Million) in In Vitro Colorectal Cancer Testing Business of Danaher Corporation (2019-2024)
    Table 45. Danaher Corporation Recent Developments
    Table 46. Epigenomics AG Basic Information List
    Table 47. Epigenomics AG Description and Business Overview
    Table 48. Epigenomics AG In Vitro Colorectal Cancer Testing Products, Services and Solutions
    Table 49. Revenue (US$ Million) in In Vitro Colorectal Cancer Testing Business of Epigenomics AG (2019-2024)
    Table 50. Epigenomics AG Recent Developments
    Table 51. Exact Sciences Corporation Basic Information List
    Table 52. Exact Sciences Corporation Description and Business Overview
    Table 53. Exact Sciences Corporation In Vitro Colorectal Cancer Testing Products, Services and Solutions
    Table 54. Revenue (US$ Million) in In Vitro Colorectal Cancer Testing Business of Exact Sciences Corporation (2019-2024)
    Table 55. Exact Sciences Corporation Recent Developments
    Table 56. LifeLabs Medical Laboratory Services Basic Information List
    Table 57. LifeLabs Medical Laboratory Services Description and Business Overview
    Table 58. LifeLabs Medical Laboratory Services In Vitro Colorectal Cancer Testing Products, Services and Solutions
    Table 59. Revenue (US$ Million) in In Vitro Colorectal Cancer Testing Business of LifeLabs Medical Laboratory Services (2019-2024)
    Table 60. LifeLabs Medical Laboratory Services Recent Developments
    Table 61. Novigenix SA Basic Information List
    Table 62. Novigenix SA Description and Business Overview
    Table 63. Novigenix SA In Vitro Colorectal Cancer Testing Products, Services and Solutions
    Table 64. Revenue (US$ Million) in In Vitro Colorectal Cancer Testing Business of Novigenix SA (2019-2024)
    Table 65. Novigenix SA Recent Developments
    Table 66. Quest Diagnostics Basic Information List
    Table 67. Quest Diagnostics Description and Business Overview
    Table 68. Quest Diagnostics In Vitro Colorectal Cancer Testing Products, Services and Solutions
    Table 69. Revenue (US$ Million) in In Vitro Colorectal Cancer Testing Business of Quest Diagnostics (2019-2024)
    Table 70. Quest Diagnostics Recent Developments
    Table 71. Sysmex Corporation Basic Information List
    Table 72. Sysmex Corporation Description and Business Overview
    Table 73. Sysmex Corporation In Vitro Colorectal Cancer Testing Products, Services and Solutions
    Table 74. Revenue (US$ Million) in In Vitro Colorectal Cancer Testing Business of Sysmex Corporation (2019-2024)
    Table 75. Sysmex Corporation Recent Developments
    Table 76. Key Raw Materials Lists
    Table 77. Raw Materials Key Suppliers Lists
    Table 78. In Vitro Colorectal Cancer Testing Downstream Customers
    Table 79. In Vitro Colorectal Cancer Testing Distributors List
    Table 80. Research Programs/Design for This Report
    Table 81. Key Data Information from Secondary Sources
    Table 82. Key Data Information from Primary Sources
    Table 83. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. In Vitro Colorectal Cancer Testing Product Picture
    Figure 2. Global In Vitro Colorectal Cancer Testing Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global In Vitro Colorectal Cancer Testing Sales Value (2019-2030) & (US$ Million)
    Figure 4. In Vitro Colorectal Cancer Testing Report Years Considered
    Figure 5. Global In Vitro Colorectal Cancer Testing Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by In Vitro Colorectal Cancer Testing Revenue in 2023
    Figure 7. In Vitro Colorectal Cancer Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Fecal Occult Blood Tests Picture
    Figure 9. Stool Biomarkers Tests Picture
    Figure 10. Blood Biomarker Tests Picture
    Figure 11. Global In Vitro Colorectal Cancer Testing Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 12. Global In Vitro Colorectal Cancer Testing Sales Value Market Share by Type, 2023 & 2030
    Figure 13. Product Picture of Ambulatory Surgical Centers
    Figure 14. Product Picture of Hospitals
    Figure 15. Product Picture of Physical Examination Center
    Figure 16. Global In Vitro Colorectal Cancer Testing Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 17. Global In Vitro Colorectal Cancer Testing Sales Value Market Share by Application, 2023 & 2030
    Figure 18. North America In Vitro Colorectal Cancer Testing Sales Value (2019-2030) & (US$ Million)
    Figure 19. North America In Vitro Colorectal Cancer Testing Sales Value by Country (%), 2023 VS 2030
    Figure 20. Europe In Vitro Colorectal Cancer Testing Sales Value (2019-2030) & (US$ Million)
    Figure 21. Europe In Vitro Colorectal Cancer Testing Sales Value by Country (%), 2023 VS 2030
    Figure 22. Asia Pacific In Vitro Colorectal Cancer Testing Sales Value (2019-2030) & (US$ Million)
    Figure 23. Asia Pacific In Vitro Colorectal Cancer Testing Sales Value by Country (%), 2023 VS 2030
    Figure 24. South America In Vitro Colorectal Cancer Testing Sales Value (2019-2030) & (US$ Million)
    Figure 25. South America In Vitro Colorectal Cancer Testing Sales Value by Country (%), 2023 VS 2030
    Figure 26. Middle East & Africa In Vitro Colorectal Cancer Testing Sales Value (2019-2030) & (US$ Million)
    Figure 27. Middle East & Africa In Vitro Colorectal Cancer Testing Sales Value by Country (%), 2023 VS 2030
    Figure 28. Key Countries/Regions In Vitro Colorectal Cancer Testing Sales Value (%), (2019-2030)
    Figure 29. United States In Vitro Colorectal Cancer Testing Sales Value, (2019-2030) & (US$ Million)
    Figure 30. United States In Vitro Colorectal Cancer Testing Sales Value by Type (%), 2023 VS 2030
    Figure 31. United States In Vitro Colorectal Cancer Testing Sales Value by Application (%), 2023 VS 2030
    Figure 32. Europe In Vitro Colorectal Cancer Testing Sales Value, (2019-2030) & (US$ Million)
    Figure 33. Europe In Vitro Colorectal Cancer Testing Sales Value by Type (%), 2023 VS 2030
    Figure 34. Europe In Vitro Colorectal Cancer Testing Sales Value by Application (%), 2023 VS 2030
    Figure 35. China In Vitro Colorectal Cancer Testing Sales Value, (2019-2030) & (US$ Million)
    Figure 36. China In Vitro Colorectal Cancer Testing Sales Value by Type (%), 2023 VS 2030
    Figure 37. China In Vitro Colorectal Cancer Testing Sales Value by Application (%), 2023 VS 2030
    Figure 38. Japan In Vitro Colorectal Cancer Testing Sales Value, (2019-2030) & (US$ Million)
    Figure 39. Japan In Vitro Colorectal Cancer Testing Sales Value by Type (%), 2023 VS 2030
    Figure 40. Japan In Vitro Colorectal Cancer Testing Sales Value by Application (%), 2023 VS 2030
    Figure 41. South Korea In Vitro Colorectal Cancer Testing Sales Value, (2019-2030) & (US$ Million)
    Figure 42. South Korea In Vitro Colorectal Cancer Testing Sales Value by Type (%), 2023 VS 2030
    Figure 43. South Korea In Vitro Colorectal Cancer Testing Sales Value by Application (%), 2023 VS 2030
    Figure 44. Southeast Asia In Vitro Colorectal Cancer Testing Sales Value, (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia In Vitro Colorectal Cancer Testing Sales Value by Type (%), 2023 VS 2030
    Figure 46. Southeast Asia In Vitro Colorectal Cancer Testing Sales Value by Application (%), 2023 VS 2030
    Figure 47. India In Vitro Colorectal Cancer Testing Sales Value, (2019-2030) & (US$ Million)
    Figure 48. India In Vitro Colorectal Cancer Testing Sales Value by Type (%), 2023 VS 2030
    Figure 49. India In Vitro Colorectal Cancer Testing Sales Value by Application (%), 2023 VS 2030
    Figure 50. In Vitro Colorectal Cancer Testing Industrial Chain
    Figure 51. In Vitro Colorectal Cancer Testing Manufacturing Cost Structure
    Figure 52. Channels of Distribution (Direct Sales, and Distribution)
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS